Institutional Ownership
Black Diamond Therapeutics I
CUSIP 09203E105COMBDTXQ1 2026
Institutional Holders
103
13F filers
Shares Held
38.51M
Aggregate institutional
Institutional Value
$54.16M
Q1 2026
Net New Holders
-1
19 new · 20 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions19
Increased30
Decreased33
Sold out20
Institutional Holders
103 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Nea Management Company, LLC | 4.45M | $9.48M | 0 | Held |
| 2 | Vanguard Capital Management LLC | 1.85M | $3.94M | +1.85M | First Filing |
| 3 | Renaissance Technologies LLC | 1.64M | $3.50M | +694.0K | Added |
| 4 | Dimensional Fund Advisors LP | 1.30M | $2.77M | +444.6K | Added |
| 5 | Blackrock, Inc. | 1.11M | $2.36M | +218.6K | Added |
| 6 | Connor, Clark & Lunn Investment Management Ltd. | 1.06M | $2.25M | +403.7K | Added |
| 7 | Mackenzie Financial Corp | 844.8K | $1.80M | +492.4K | Added |
| 8 | Marshall Wace, LLP | 836.3K | $1.78M | −273.8K | Reduced |
| 9 | Arrowstreet Capital, Limited Partnership | 834.6K | $1.78M | −205.9K | Reduced |
| 10 | Bridgeway Capital Management, LLC | 723.5K | $1.54M | +550.2K | Added |
93 more institutional holders on Premium
See every fund holding Black Diamond Therapeutics I, with full quarter-over-quarter share changes.
Unlock all holders